Blocking GSK3β reduces colitis severity in a mouse study

Science Signaling reports that methyl pyruvate shifted cultured human T helper 1 cells away from glycolysis, reducing their inflammatory activity. A GSK3β inhibitor also reduced colitis severity in mice. The researchers identify the enzyme as a potential therapeutic target for inflammatory bowel disease.